biomedicina slovenica

re="Eur J Cancer" : 137

  1. Siesling Sabine; Primic-Žakelj Maja
    Rare thoracic cancers, including peritoneum mesothelioma
    2012 ►
  2. Sodja Eva; Knez Lea; Kern Izidor; Ovčariček Tanja; Sadikov Aleksander; Čufer Tanja
    Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy
    2012 ►
  3. Gatta Gemma; Primic-Žakelj Maja
    Rare cancers are not so rare: the rare cancer burden in Europe
    2011 ►
  4. Trama A; Mallone S; Nicolai N; Necchi A; Schaapveld M; Gietema J; Znaor A; Ardanz E; Berrino F; Primic-Žakelj Maja
    Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe
    2012 ►
  5. Amir Eitan; Šeruga Boštjan; Kwong Ryan; Tannock Ian; Ocaña Alberto
    Poor correlation between progression-free and overall survival in modern clinical trials: are composite endpoints the answer?
    2012 ►
  6. Van Dijk BAC; Gatta Gemma; Capocaccia R; Pierannunzio Daniela; Strojan Primož; Licitra Lisa
    Rare cancers of the head and neck area in Europe
    2012 ►
  7. Bränström Richard; Hočevar Marko; Perić Barbara
    Melanoma risk factors, perceived threat and intentional tanning: an international online survey
    2010 ►
  8. Rosso Stefano; Primic-Žakelj Maja; Žagar Tina
    Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United States
    2010 ►
  9. Kenig S; Majdič T; Duran-Alonso MB; Lah T
    Endothelial cells increase invasiveness of glioblastoma cells and protect them from apoptosis
    2010 ►
  10. Sant Milena; Primic-Žakelj Maja
    EUROCARE-4, survival of cancer patients diagnosed in 1995-1999: results and commentary
    2009 ►
  11. Sant Milena; Primic-Žakelj Maja
    Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study
    2007 ►
  12. Gondos A.; Primic-Žakelj Maja
    Recent trends in cancer survival across Europe between 2000 and 2004: #a #model-based period analysis from 12 cancer registries
    2008 ►
  13. Robins G.; Primic-Žakelj Maja; Potočnik Marjeta
    International variation in Helicobacter pylori infection and rates of oesophageal cancer
    2008 ►
  14. Bouvier Anne-Marie; Pompe-Kirn Vera
    What reasons lie behind long-term survival differences for gastric cancer within Europe?
    2010 ►
  15. De Angelis Roberta; Primic-Žakelj Maja
    The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis
    2009 ►
  16. Berrino Franco; Primic-Žakelj Maja
    Comparative cancer survival information in Europe
    2009 ►
  17. Quaglia Alberto; Primic-Žakelj Maja
    The cancer survival gap between elderly and middle-aged patients in Europe is widening
    2009 ►
  18. Gatta Gemma; Primic-Žakelj Maja
    Survival of European children and young adults with cancer diagnosed 1995-2002
    2009 ►
  19. Anttila Ahti; Primic-Žakelj Maja; Pogačnik Ana; Uršič-Vrščaj Marjetka; Zadnik Vesna
    Description of the national situation of cervical cancer screening in the member states of the European Union
    2009 ►
  20. Rosso Stefano; Primic-Žakelj Maja
    Multiple tumours in survival estimates
    2009 ►
  21. Francisci Silvia; Primic-Žakelj Maja
    The cure of cancer: a European perspective
    2009 ►
  22. Verdecchia Arduino; Primic-Žakelj Maja
    Survival trends in European cancer patients diagnosed from 1988 to 1999
    2009 ►
  23. Brenner Hermann; Primic-Žakelj Maja
    Long-term survival expectations of cancer patients in Europe in 2000-2002
    2009 ►
  24. Micheli Andrea; Primic-Žakelj Maja
    The advantage of women in cancer survival: an analysis of EUROCARE-4 data
    2009 ►
  25. Ravnik M; Snoj N; Sadikov A; Nussdorfer P; Čufer T
    Comparison of adjuvant! Online prediction with 10-year follow-up results according to the uPA and PAI-1 levels in Slovenian early breast cancer patients
    2010 ►
  26. Maule Milena M.; Pompe-Kirn Vera
    Risk of second malignant neoplasms after childhood central nervous system malignant tumours: #an #international study
    2008 ►
  27. Nicula Florian A.; Anttila Ahti; Neamtiu Luciana; Primic-Žakelj Maja; Tachezy Ruth; Chil Arkadiusz; Grce Magdalena; Kesić Vesna
    Challenges in starting organised screening programmes for cervical cancer in the member states of the European Union
    2009 ►
  28. Ronco Guglielmo; van Ballegoijen Marjolein; Becker Nicolas; Rebolj Matejka; Primic-Žakelj Maja
    Process performance of cervical screening programmes in Europe
    2009 ►
  29. Čufer Tanja; Pajk Bojana; Borštnar Simona
    Individualised systemic treatment
    2006 ►
  30. Ravnik Maja; Takač Iztok; Arko Darja; Gorišek Borut; Čas-Sikošek Nina; Lampelj Maja; Ravnik Janez; Čufer Tanja
    Expression of invasive markers (uPA/PAI-1) in four different HER2, ER, PR subgroups of early breast cancer
    2008 ►
  31. Zielinski Christoph C.; Awada Ahmad; Cameron David A.; Čufer Tanja; Martin Miguel; Aapro Matti S.
    The impact of new European organisation for research and treatment of cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients
    2008 ►
  32. Hočevar Marko; Auersperg Marija
    Use of serum thyroglobulin for monitoring the effect of chemotherapy and irradiation in differentiated thyroid cancer
    1995 ►
  33. Auersperg Marija; Us-Krašovec Marija; Pogačnik Ana; Hočevar Marko; Palčič Branko; Garner D
    Vinblastine (VBL) in differentiated thyroid carcinoma (DTC) effect monitored by DNA measurements
    1995 ►
  34. Cataliotti L.; Čufer Tanja
    Guidelines on the standards for the training of specialised health professionals dealing with breast cancer
    2007 ►
  35. Tuohimaa P; Pukkala E; Scelo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V
    Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation
    2007 ►
  36. Marty Michel; Serša Gregor; Snoj Marko; Miklavčič Damijan; Pavlović Ivan; Paulin-Košir Marija Snežna; Čemažar Maja; Rudolf Zvonimir
    Electrochemotherapy - an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases : results of ESOPE (European standard operating procedures of electrochemotherapy) study
    2006 ►
  37. Snoj Marko; Rudolf Zvonimir; Paulin-Košir Marija Snežna; Čemažar Maja; Snoj Rudolf; Serša Gregor
    Long lasting complete response in melanoma treated by electrochemotherapy
    2006 ►
  38. Serša Gregor
    The state-of-the-art of electrochemotherapy before the ESOPE study : advantages and clinical uses
    2006 ►
  39. Mir Lluis Maria; Gehl J; Serša Gregor; Collins Christopher G.; Garbay JR; Billard Valérie; Geertsen PF; Rudolf Zvonimir; O'Sullivan Gerald C; Marty Michel
    Standard operating procedures of the electrochemotherapy : instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator TM by means of invasive or non-invasive electrodes
    2006 ►
  40. Morales Leilani; Čufer Tanja
    Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer : a randomised phase III trial of the European Organis[!]ation for Research and Treatment of Cancer Breast Group
    2007 ►
  41. Steliarova-Foucher E; Kaatsch P; Lacour B; Pompe-Kirn V; Eser S; Miranda A; Danzon A; Ratiu A; Parkin DM
    Quality, compaability and methods of analysis of data on childhood cancer in Europe (1978-1997)
    2006 ►
  42. Jelen-Jurič J; Prijatelj B; Lokar K
    Advanced course for nurses as the first step towards quality improvement of vascular access port management
    2005 ►
  43. Globokar T; Snoj Nataša; Sadikov A; Čufer T
    Amenorrhea as a prognostic factor in premenopausal endocrine responsive early breast cancer patients
    2006 ►
  44. Snoj Nataša; Globokar T; Sadikov A; Čufer T
    Correlation between hormonal receptor levels and efficacy of hormonal therapy and chemotherapy in metastatic breast cancer
    2006 ►
  45. Lokar K
    The knowledge of young men about testicular cancer and their attitudes toward it
    2001 ►
  46. Strojan P; Zakotnik B; Šmid L; Karner K; Šoba E
    Concomitant radiochemotherapy with Mitomycin C and Cisplatin in inoperable carcinoma of the head and neck: preliminary results of phase II study
    2005 ►
  47. Oblak I; Strojan P; Gale N; Mid L
    Expression of cystein proteases cathepsin B in inoperative squamous cell carcinoma of the head and neck
    2005 ►
  48. Skela-Savič B; Strojan P; Lokar K
    Identification of the needs for organized palliative care in radiation oncology
    2005 ►
  49. Garbay JR; Serša G; O'Sullivan GC; Gehl J; Cadossi R; Mir L
    Results of the ESOPE multicentre study on electrochemotherapy
    2005 ►
  50. Rudolf Z; Serša G; Gehl J; O'Sullivan GC; Garbay JR; Cadossi R; Mir LM
    Indications for treatment by electrochemotherapy; results of the ESOPE European trials
    2005 ►
  51. Lokar K; Skela-Savič B
    Quality management in patient care at the Institute of oncology Ljubljana
    2005 ►
  52. Žgajnar Janez; Bešić Nikola; Podkrajšek Maja; Hertl Kristjana; Frković-Grazio Snježana; Hočevar Marko
    Minimal risk of macrometastases in the non-sentinel axillary lymph nodes in breast cancer patients with micrometastatic sentinel lymph nodes and preoperatively ultrasonically uninvolved axillary lymph nodes
    2005 ►
  53. Paridaens R; Therasse P; Dirix L; Beex L; Piccart MJ; Cameron D; Čufer T; Roozendael K; Nooy M; Mattiacci MR
    First results of a randomized phase III trial comparing exemestane versus tamoxifen as first-line hormone therapy (HT) for postmenopausal women with metastatic breast cancer (MBC) - EORTC 10951 in collaboration with the exemestane working group and NCIC clinical trials group
    2004 ►
  54. Matos E; Borstnar S; Vrhovec I; Svetič B; Čufer T
    PAI-1 and PAI-2 as predictive factors in breast cancer
    2004 ►
  55. Drev P; Golouh R; Snoj Nataša; Čufer T
    Correlation between Her-2 status in primary tumour and response to anastrozole in patients with metastatic breast cancer
    2004 ►
  56. Pajk B; Borštnar S; Snoj Nataša; Čufer T
    Disease free survival (DFS) in breast cancer patients older than 70 years compered to younger patients groups
    2004 ►
  57. Paridaens R; Dyczka J; Rutgers EJT; Coleman R; Čufer T; Jassem J; Nortier JRW; Morales L; Mattiacci MR; Therasse P; Gasthuisberg UZ
    Postoperative adjuvant chemotherapy folowed by adjuvant tamoxifen versus nil for patients with operable breast cancer. First results of a randomized phase III trial EORTC 10901
    2004 ►
  58. Snoj Nataša; Pajk B; Borštnar S; Čufer T
    The benefits of adjuvant hormonal therapy in patients with early breast cancer 35 years old or younger
    2004 ►
  59. Piškur P; Sonc M; Čufer T; Borštnar S; Mrhar A
    Pharmacoeconomics aspects of adjuvant early breast cancer treatment in postmenopausal women with anastrozole or tamoxifen: a Slovenian perspective
    2004 ►
  60. Atalay G; Biganzoli L; Renard F; Paridaens R; Čufer T; Coleman R; Calvert AH; Gamucci T; Minisini A; Therasse P
    Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials
    2003 ►
  61. Podkrajšek M; Hertl K; Hočevar M; Žgajnar J; Bešić N; Bračko M
    Axillary ultrasound (US) and US-guided fine needle aspiration biopsy in the assessment of lymph-node metastases in breast cancer patients
    2003 ►
  62. Velepič M; Skela-Savič B; Koren P
    An impact of internal quality control in oncology nursing care
    2003 ►
  63. Strojan P; Svetic B; Šmid L; Kos J
    Cysteine proteinase inhibitor cystatin C (CC) in operable squamous cell carcinoma of the head and neck (SCCHN): expression pattern and relation to prognosis
    2003 ►
  64. Oblak I; Strojan P; Zakotnik B; Budihna M; Šmid L
    Hemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapy
    2003 ►
  65. Bešić N; Žgajnar J; Bergant D; Hočevar M; Pompe F
    Prognostic factors in follicular and Huerthle cell carcinoma of the thyroid gland - a multivariate survival analysis
    2003 ►
  66. Bergant D; Glavač D; Bešić N; Hočevar M
    Medullary thyroid carcinoma (MTC): genetic screening in Slovenia 1997-2002
    2003 ►
  67. Snoj M; Vidergar-Kralj B
    Added value of blue dye in sentinel node biopsy for breast cancer
    2003 ►
  68. Hočevar M; Bračko M; Pogačnik A; Vidergar-Kralj B; Bešić N; Žgajnar J
    Role of imprint cytology in the intraoperative evaluation of sentinel lymph nodes for malignant melanoma
    2003 ►
  69. Lokajner G; Laznik K; Plenovski-Plevčak D
    Collaboration between oncology unit and pharmacy department - benefits for nursing practice
    2001 ►
  70. Bonnefoi H; Biganzoli L; Mauriac L; Čufer T; Schaefer P; Atalay G; Piccart M
    An EORTC phase I study of capecitabine (xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer
    2003 ►
  71. Čemažar M; Auersperg M; Ščančar J; Srebotnik-Kirbiš I; Pogačnik A; Serša G
    Interactions between vinblastine and cisplatin in EAT tumours in mice: schedule dependency
    2002 ►
  72. Ećimović P; Pompe-Kirn V
    Second primary cancers in laryngeal cancer patients in Slovenia, 1961-1996
    2002 ►
  73. Herzog Branka; Hendrick JC; Franchimont P
    Heterogeneity of carcinoemenbryonic antigen (CEA) in human serum
    1976 ►
  74. Čufer T
    Symptomatic and supportive care in metastatic disease
    2002 ►
  75. Awada A; Biganzoli L; Čufer T; Beex L; Lohrisch C; Batter V; Hamilton A; Nooij M; Piccart M
    An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes
    2002 ►
  76. Brodowicz T; Beslija S; Červek J; Mršič-Krmpotič Z; Tchernozemsky I; Wiltschke C; Ghilezan N; Grgič M; Jassem J; Zielinski C
    Gemcitabine, epirubicin and paclitaxel (GET) vs. 5-fluoro-uracil, epirubicin and cyclophosphamide (FEC) as first-line treatment in metastatic breast cancer: interim toxicity analysis of a randomised, multicenter phase iii trial of the Central European cooperative oncology group (CECOG)
    2001 ►
  77. Biganzoli L; Bonnefoi H; Mauriac L; Čufer T; Kabanga-Ngalula E; Hebert D; Piccart M
    Cyclophosphamide (C) - Epirubicine (E) - Capecitabine (X) combination, CEX: a safe and active regimen in the treatment of locally advanced/inflammatory (LA/I) or large operable (LO) breast cancer (BC). An EORTC-IDBBC study
    2001 ►
  78. Žgajnar J; Hočevar M; Bešić N; Vrščaj M; Pajk B; Čufer T; Jakopin C; Krajc M
    Genetic counceling for hereditary breast and ovarian cancer. Our experience at the Institute of oncology in Ljubljana, Slovenija
    2002 ►
  79. Jagodic M; Vrhovec I; Borštnar S; Matos E; Čufer T
    Prognostic value of different proteolitic factors in primary breast cancer
    2002 ►
  80. Matos E; Vrhovec I; Borštnar S; Jagodic M; Čufer T
    Predictive value of PAI-1 and PAI-2 in breast cancer
    2002 ►
  81. Pajk B; Borštnar S; Vrhovec I; Čufer T
    PAI-1 is independant prognostic factor in the elderly breast cancer patients
    2002 ►
  82. Hočevar M; Glumac N; Novaković S; Snoj M
    The role of serum S-100 protein and thyrosinase RT-PCR in staging patients with malignant melanoma
    2001 ►
  83. Kranjc Simona; Čemažar Maja; Grošel Alenka; Serša Gregor
    Antivascular effect of electrochemotherapy with cisplatin
    2001 ►
  84. Coebergh J-W; Pastore G; Gatta G; Corazziari I; Kamps W; Pompe-Kirn V
    Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978-1992: the EUROCARE study
    2001 ►
  85. Sant M; Capocaccia R; Coleman MP; Berrino F; Gatta G; Micheli A; Verdecchia A; Faivre J; Hakulinen T; Pompe-Kirn V
    Cancer survival increases in Europe, but international differences remain wide
    2001 ►
  86. Gatta G; Luksch R; Coleman MP; Corazziari I; Pompe-Kirn V
    Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population-based study
    2001 ►
  87. Levi F; La Vecchia C; Negri E; Lucchini F; Pompe-Kirn V
    Childhood cancer mortality in Europe, 1955-1995
    2001 ►
  88. Terracini B; Coebergh J-W; Gatta G; Magnani C; Stiller C; Verdecchia A; Zappone A; Pompe-Kirn V
    Childhood cancer survival in Europe: an overview
    2001 ►
  89. Stiller CA; Craft AW; Corazziari I; Pompe-Kirn V
    Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study
    2001 ►
  90. Storm HH; Plesko I; Pompe-Kirn V
    Survival of children with thyroid cancer in Europe 1978-1989
    2001 ►
  91. Moeller TR; Garwicz S; Corazziari I; Magnani C; Pompe-Kirn V
    Survival of children with liver tumours in Europe 1978-1989
    2001 ►
  92. Kramarova E; Mann JR; Magnani C; Corraziari I; Berrino F; Pompe-Kirn V
    Survival of children with malignant germ cell, trophoblastic and other gonadal tumours in Europe
    2001 ►
  93. Stiller CA; Stevens MCG; Magnani C; Corazziari I; Pompe-Kirn V
    Survival of children with soft-tissu sarcoma in Europe since 1978: results from the EUROCARE study
    2001 ►
  94. Conti EMS; Cercato MC; Gatta G; Ramazzotti V; Roscioni S; Pompe-Kirn V
    Childhood melanoma in Europe since 1978: a population-based survival study
    2001 ►
  95. Magnani C; Gatta G; Corazziari I; Kramarova E; Pastore G; Viscomi S; Stiller C; Pompe-Kirn V
    Childhood malignancies in the EUROCARE study: the database and the methods of survival analysis
    2001 ►
  96. Čemažar M; Miklavčič D; Mir LM; Belehradek J-Jr; Bonnay M; Fourcault D; Serša G
    Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model
    2001 ►
  97. Pastore G; Magnani C; Verdecchia A; Pession A; Viscomi S; Coebergh JW; Oberaigner W; Storm H; Aareleid T; Pompe-Kirn V
    Survival of childhood lymphomas in Europe, 1978-1992: a report from the EUROCARE study
    2001 ►
  98. Magnani C; Aareleid T; Viscomi S; Pastore G; Berrino F; Oberaigner W; Storm H; Hakulinen T; Mace-Lesec'h J; Pompe-Kirn V
    Variation in survival of children with central nervous system (CNS) malignancies diagnosed in Europe between 1978 and 1992: the EUROCARE study
    2001 ►
  99. Sant M; Capocaccia R; Badioni V; Oberaigner W; Storm H; Aareleid T; Hakulinen T; Mace-Lesec'h J; Arveux P; Pompe-Kirn V
    Survival for retinoblastoma in Europe
    2001 ►
  100. Spix C; Aareleid T; Stiller C; Magnani C; Kaatsch P; Michaelis J; Oberaigner W; Storm H; Aareleid T; Pompe-Kirn V
    Survival of children with neuroblastoma. time trends and regional differences in Europe, 1978-1992
    2001 ►

1 101  

Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko